Cargando…
Erratum to: Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients
Autores principales: | Chen, Lu, Lin, Lanyi, Zhou, Huijuan, Tang, Weiliang, Wang, Hui, Cai, Wei, Bao, Shisan, Guo, Simin, Xie, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691159/ https://www.ncbi.nlm.nih.gov/pubmed/34950746 http://dx.doi.org/10.1093/ofid/ofab354 |
Ejemplares similares
-
Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients
por: Chen, Lu, et al.
Publicado: (2020) -
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
por: Yan, Lei, et al.
Publicado: (2018) -
A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients
por: Liu, Kehui, et al.
Publicado: (2016) -
Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
por: Yu, Jiao, et al.
Publicado: (2022) -
Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
por: Imaging, Contrast Media & Molecular
Publicado: (2023)